Medications for pregnant women: A balancing act between the interests of the mother and of the fetus
- 26 April 2020
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 40 (9) , 1156-1167
Abstract
Drug entry into the adult brain is controlled by efflux mechanisms situated in various brain barrier interfaces. The effectiveness of these protective mechanisms in the embryo, fetus and newborn brain is less clear. The longstanding belief that “the” blood‐brain barrier is absent or immature in the fetus and newborn has led to many misleading statements with potential clinical implications. Here we review the properties of brain barrier mechanisms in the context of drug entry into the developing brain and discuss the limited number of studies published on the subject. We noticed that most of available literature suffers from some experimental limitations, notably that drug levels in fetal blood and cerebrospinal fluid have not been measured. This means that the relative contribution to the overall brain protection provided by individual barriers such as the placenta (which contains similar efflux mechanisms) and the brain barriers cannot be separately ascertained. Finally, we propose that systematic studies in appropriate animal models of drug entry into the brain at different stages of development would provide a rational basis for use of medications in pregnancy and in newborns, especially prematurely born, where protection usually provided by the placenta is no longer present.Keywords
Funding Information
- Cass Foundation (7981)
This publication has 63 references indexed in Scilit:
- Genome sequence of an Australian kangaroo, Macropus eugenii, provides insight into the evolution of mammalian reproduction and developmentGenome Biology, 2011
- Differential expression of the multidrug resistance‐related proteins ABCb1 and ABCc1 between blood‐brain interfacesJournal of Comparative Neurology, 2008
- Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral-spinal fluid barrier by in vivo biotinylationNeuroscience, 2008
- ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNSNeuropediatrics, 2008
- The blood–CSF barrier explained: when development is not immaturityBioEssays, 2008
- Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequencesNature, 2007
- Blood–CSF barrier function in the rat embryoEuropean Journal of Neuroscience, 2006
- DISTRIBUTION OF 2 4 DICHLOROPHENOXYACETIC ACID 2 4 D IN MATERNAL AND FETAL RABBITSJournal of Toxicology and Environmental Health, 1996
- Ontogenic expression of the erythroid-type glucose transporter (Glut 1) in the telencephalon of the mouse: correlation to the tightening of the blood-brain barrierDevelopmental Brain Research, 1995
- Cell junctions and membrane specializations in the ventricular zone (germinal matrix) of the developing sheep brain: A CSF-brain barrierJournal of Neurocytology, 1987